Journal of Clinical Endocrinology & Metabolism, Vol 62, 827-832, Copyright © 1986 by Endocrine Society

ARTICLES

Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes

Y Kawai, A Powell and IJ Arinze

Adrenergic receptors in human liver plasma membranes were characterized by radioligand binding assays. The binding of [3H]dihydroalprenolol [( 3H]DHA) to partially purified membranes was rapid, of high affinity, saturable, and stereospecific. The binding of [125I]iodocyanopindolol to the same membranes was also saturable and stereospecific, but extremely slow, and at 37 C required about 6 h for equilibration. The maximum number of binding sites from six livers determined with these two beta-receptor ligands was 36-83 fmol/mg protein. Catecholaminergic agonists competed for these binding sites in the order typical for beta 2-adrenergic receptors. IPS 339 [(tertiarybutylamino-3-ol-2- propyl)oximino-9-fluorene hydrochloride], a beta 2-selective antagonist, was at least 3 orders of magnitude more potent in inhibiting the binding of [3H]DHA than the beta 1-antagonist, atenolol. Computer-aided analysis of the competition curves as well as Hofstee transformations of the binding data indicated the predominance of the beta 2-subtype. The GTP analog guanyl-5'-yl-imidodiphosphate, decreased the binding affinity of the agonist, l-isoproterenol, indicating the modulation of agonist-promoted coupling of the receptors to guanine nucleotide regulatory proteins. The maximum number of binding sites for the binding of [3H]prazosin and [3H]dihydroergocryptine were the same (60-70 fmol/mg protein), indicating that the majority of the alpha- receptors are of the alpha 1-subtype. Competition experiments with prazosin and yohimbine confirmed the predominance of the alpha 1- receptor subtype, although the presence of alpha 2-receptors cannot be completely ruled out. These results indicate that adrenergic receptors in human liver plasma membranes are predominantly of the beta 2- and alpha 1-subtypes.

This article has been cited by other articles:

				C. A. Chu, D. K. Sindelar, K. Igawa, S. Sherck, D. W. Neal, M. Emshwiller, and A. D. Cherrington The direct effects of catecholamines on hepatic glucose production occur via alpha 1- and beta 2-receptors in the dog Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E463 - E473. [Abstract] [Full Text] [PDF]

				J. Yang, L.-W. Dong, C. Tang, and M.-S. Liu Transcriptional and posttranscriptional regulation of beta 2-adrenergic receptor gene in rat liver during sepsis Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R132 - R139. [Abstract] [Full Text] [PDF]

				C. A. Chu, D. K. Sindelar, D. W. Neal, E. J. Allen, E. P. Donahue, and A. D. Cherrington Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E162 - E171. [Abstract] [Full Text] [PDF]

				C. J. O'Callaghan, K. Komersova, and W. J. Louis Acute Effects of Blood Pressure Elevation on Insulin Clearance in Normotensive Healthy Subjects Hypertension, January 1, 1998; 31(1): 104 - 109. [Abstract] [Full Text] [PDF]